![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Thursday, July 30, 2020 4:23:14 PM
I don't think COVID-19 is going anywhere in the near-term. So I'm not saying to only focus or not focus on coronavirus vaccine stocks. But what I am saying is that biotechnology and healthcare penny stocks are making waves in the market. With this in mind, here's a list of a few names gaining attention this year.
Biotech Penny Stocks To Watch: Revive Therapeutics
Revive Therapeutics (RVVTF Stock Report) (RVV) has made a strong move in 2020. The company focuses on several areas of the healthcare market. It has a treatment it's working to advance for addressing coronavirus. It also has taken a directive to build IP around psychedelics. With its acquisition of Psilocin Pharma Corp., Revive is developing Psilocybin-based therapeutics in various diseases and disorders.
However, the more recent focus has been on its COVID-19 side. At the end of June, Revive announced the submission of an Investigational New Drug application to the U.S. FDA. This was for a Phase 3 confirmatory study for Bucillamine. The trial is to see Bucillamine as a potential treatment in COVID-19.
Once the U.S. FDA allows the IND to go into effect, Revive said it will initiate a randomized, double-blind, placebo-controlled study of Bucillamine in patients with mild-moderate COVID-19 in Q3-2020.
The company has also previously met with Health Canada in a Pre-Clinical Trial Application meeting. Revive also said that it intends to follow up with the submission of the complete CTA package for Health Canada around its Phase 3 study as part of the same multinational clinical strategy.
From a technical perspective, the Revive chart has been following closely with its 50 Day Moving Average. Furthermore, since the end of June, the average daily volume has also been picking up. Will these recent developments continue acting as a catalyst for Revive heading into August?
https://www.marketwatch.com/press-release/are-these-penny-stocks-on-your-biotech-watch-list-2020-07-27
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM